Prophylactic cranial irradiation (PCI). Still a no-brainer?

Area of Science:

• Oncology
• Radiation Oncology
• Neurology

Background:

• Prophylactic cranial irradiation (PCI) has been a long-standing treatment for limited-stage small cell lung cancer.
• Recent advancements question the necessity and optimal application of PCI.
• Factors include evolving patient selection criteria, updated imaging, and understanding radiation's side effects.

Purpose of the Study:

• To review current evidence on optimizing patient selection for PCI.
• To explore potential improvements in radiation delivery techniques for PCI.
• To address the evolving role of PCI in limited-stage small cell lung cancer management.

Main Methods:

• Literature review of studies on PCI in small cell lung cancer.
• Analysis of data on patient selection and treatment outcomes.
• Examination of emerging radiation technology and its impact on PCI.

Main Results:

• Evidence suggests a need for more precise patient selection criteria.
• Newer radiation techniques may mitigate side effects of whole brain irradiation.
• Ongoing research aims to balance cancer control with neurocognitive preservation.

Conclusions:

• The role of PCI in limited-stage small cell lung cancer requires re-evaluation based on individual patient factors.
• Future strategies should focus on personalized treatment approaches.
• Improving radiation delivery is key to minimizing long-term adverse effects.